| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 2 sells. REPL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 533.6K | $5.97M | - | |
| Other | 201.6K | $2.25M | - | |
| Other | 199.7K | $2.23M | - | |
| CFO | 194.4K | $2.17M | - | |
| Other | 78.3K | $875.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2019 | Astley-Sparke Philip47 | Executive Chairman | Sell | 14,500 | $17.05 | $247,225.00 | -1.0% | |
| Sep 23, 2019 | Love Colin72 | Chief Operating Officer | Sell | 11,250 | $17.05 | $191,812.50 | -1.0% | |
| Jul 24, 2018 | Forbion Capital Fund III Cooperatief U.A. | 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +2.9% | |
| Jul 24, 2018 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 500,000 | $15.00 | $7,500,000.00 | +21.4% | |
| Jul 24, 2018 | Slootweg Hugo Alexander | Director, 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +2.9% | |
| Jul 24, 2018 | Slattery Joseph P | Director | Buy | 6,667 | $15.00 | $100,005.00 | New | |
| Jul 24, 2018 | Omega Fund Iv, L.P.81 | 10% Owner | Buy | 266,667 | $15.00 | $4,000,005.00 | New |